Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs directed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline We https://financefeeds.com/chfjpy-technical-analysis-report-7-february-2025/